Literature DB >> 10419020

Characterization of UDP-glucuronosyltransferases active on steroid hormones.

D W Hum1, A Bélanger, E Lévesque, O Barbier, M Beaulieu, C Albert, M Vallée, C Guillemette, A Tchernof, D Turgeon, S Dubois.   

Abstract

In recent years, the enzymes which are involved in the formation of DHT in steroid target tissues have been well investigated, however, enzymes responsible for the catabolism and elimination of steroids in these tissues, in particular the uridine diphospho-glucuronosyltransferase (UGT) family of enzymes, have received much less attention. We have recently demonstrated that human and monkey are unique in having high plasma levels of C19 steroid glucuronides. These circulating conjugates have been proposed to reflect the peripheral conversion of adrenal and gonadal C19 steroids to potent androgens, especially DHT. In humans, the presence of steroid UGT activities is found in the liver and several extrahepatic tissues including the prostate, mammary gland and ovary. In addition, UGT activities were observed in breast and prostate tumor cell lines such as MCF-7 and LNCaP, respectively. In agreement with the presence of steroid conjugating enzymes in extrahepatic tissues, UGT cDNA clones, which encode steroid conjugating proteins, have been isolated from libraries constructed from human and monkey prostate mRNA. The presence of UGT transcripts and proteins in extrahepatic tissues in both species, as determined by Northern blot, ribonuclease protection, specific RT-PCR, in situ hybridization, Western blot and immunocytochemistry analysis, indicate the relevance of steroid glucuronidation in tissues other than the liver. Knowing that both the human prostate and the human prostate cancer LNCaP cell line express steroid metabolizing proteins, including UGT enzymes, regulation of UGT mRNA and protein levels, as well as promoter activity was studied in these cells. The results demonstrate a differential regulation between the two highly related isoforms UGT2B15 and UGT2B17, where only the expression of UGT2B17 was affected following treatments of LNCaP cells with androgens, growth factors or cytokines. Steroid conjugation by UGT enzymes is potentially involved in hormone inactivation in steroid target tissues, thus modifications in UGT expression levels may influence hormonal responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419020     DOI: 10.1016/s0960-0760(99)00061-8

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  24 in total

1.  Testicular vs adrenal sources of hydroxy-androgens in prostate cancer.

Authors:  Tianzhu Zang; Mary-Ellen Taplin; Daniel Tamae; Wanling Xie; Clementina Mesaros; Zhenwei Zhang; Glenn Bubley; Bruce Montgomery; Steven P Balk; Elahe A Mostaghel; Ian A Blair; Trevor M Penning
Journal:  Endocr Relat Cancer       Date:  2017-06-29       Impact factor: 5.678

2.  Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.

Authors:  Ebrahim Eskandari-Nasab; Mohammad Hashemi; Hamzeh Rezaei; Aliakbar Fazaeli; Mohammad Ali Mashhadi; Simin Sargholzaei Moghaddam; Farshid Arbabi; Mahdi Jahantigh; Mohsen Taheri
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

Review 3.  Sex steroids and potential mechanisms of non-genomic endocrine disruption in invertebrates.

Authors:  Gemma Janer; Cinta Porte
Journal:  Ecotoxicology       Date:  2007-02       Impact factor: 2.823

4.  Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity.

Authors:  Carla J Gallagher; Renee M Balliet; Dongxiao Sun; Gang Chen; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2010-09-01       Impact factor: 3.922

5.  SNP discovery, expression and cis-regulatory variation in the UGT2B genes.

Authors:  C Sun; C Southard; D Huo; R D Hernandez; D B Witonsky; O I Olopade; A Di Rienzo
Journal:  Pharmacogenomics J       Date:  2011-03-01       Impact factor: 3.550

6.  Xenobiotic Metabolism in Mice Lacking the UDP-Glucuronosyltransferase 2 Family.

Authors:  Matthew J Fay; My Trang Nguyen; John N Snouwaert; Rebecca Dye; Delores J Grant; Wanda M Bodnar; Beverly H Koller
Journal:  Drug Metab Dispos       Date:  2015-09-09       Impact factor: 3.922

7.  Developmental aspects of human hepatic drug glucuronidation in young children and adults.

Authors:  C P Strassburg; A Strassburg; S Kneip; A Barut; R H Tukey; B Rodeck; M P Manns
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

8.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29

9.  Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones.

Authors:  Caroline Girard; Olivier Barbier; David Turgeon; Alain Bélanger
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

10.  UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation.

Authors:  N Santos; R Rodríguez-Romanos; J B Nieto; I Buño; C Vallejo; A Jiménez-Velasco; S Brunet; E Buces; J López-Jiménez; M González; C Ferrá; A Sampol; R de la Cámara; C Martínez; D Gallardo
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.